Curaleaf Takes Full Control of European Arm in Bold Strategic Move

LOS ANGELES – In a major development out of the cannabis industry, Curaleaf Holdings, Inc. (TSX: CURA, OTCQX: CURLF) has just announced it’s taken full ownership of Curaleaf International, buying out its minority partner’s stake in a deal finalized on July 2. Sources confirm the transaction, executed through a 2021 Put/Call Option agreement, hands Curaleaf complete control of its European operations.

The move is a game-changer, giving Curaleaf the freedom to call the shots in Europe’s fast-growing medical cannabis market. Just this year, the company made headlines with regulatory approval for a cutting-edge handheld inhalation device, a first for the continent. It’s a sign Curaleaf is doubling down on innovation, with plans to roll out this EU-certified tech across Europe, the UK, and even Australia, where they launched new products in May.

But it’s not all smooth sailing. Back in the U.S., Curaleaf reported a 9% revenue drop to $310 million in Q1 2025, hit hard by domestic competition and regulatory hurdles. Still, their international sales spiked 74%, signaling Europe could be their ticket to growth. The company’s also shaking things up with new leadership, former Albertsons exec Rahul Pinto stepped in as President, joined by three new Senior VPs to sharpen their global edge.

With the minority partner accepting payment in shares, confidence in Curaleaf’s vision is clear, even as its stock has slumped 46% this year. As the cannabis giant sets its sights on Europe’s green frontier, all eyes are on whether this bold buyout will spark a turnaround.